Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder

NCT04945057 is registered in ClinicalTrials.gov with National Institute of Mental Health, Czech Republic as lead sponsor.

NCT NCT04945057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04945057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AKTIBIPO-VALIDATION: A Study to Validate Benefits of Mindpax System in Managing Bipolar Disorder
Lead sponsor
National Institute of Mental Health, Czech Republic
Phase
Not applicable
Overall status
Unknown status
Start date
May 5, 2021
Completion date
December 31, 2023
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder